Crinetics Pharmaceuticals
Congress has disclosed 4 buys and 1 sell of CRNX (Crinetics Pharmaceuticals) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying CRNX and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Gilbert Cisneros | 2026-03-03 | $40.12 | $84.95 | +111.7% | in profit |
Price as of 2026-09-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
5 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2026-03-03 | 34 days | -6.0% | $1K–$15K 0.1% of NW |
17.1 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2025-04-17 | 18 days | +10.6% | $1K–$15K 0.1% of NW |
27.3 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-03-19 | 16 days | -22.4% | $1K–$15K <0.1% of NW |
26.0 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self · 150 Main Street Trust > Bank of America | 2025-01-29 | 8 days | -1.7% | $1K–$15K 0.1% of NW |
62.9 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-09-25 | 8 days | +4.6% | $1K–$15K <0.1% of NW |
62.4 | ↗ filing |
FAQ Common questions
How much has Congress traded CRNX?
4 disclosed buys and 1 sells of CRNX (Crinetics Pharmaceuticals) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade CRNX?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.